Progressive Oncology & Hematology’s $1.45 Million FCA Settlement Exposes Systematic Chemotherapy Drug Billing Fraud Against Medicare, Medicaid, and the VA

Short summary

Progressive Oncology and Hematology LLC agreed to a $1.45 million settlement for False Claims Act violations involving systematic chemotherapy billing fraud. The practice billed for drugs never purchased (including charity donations), split single-use vials across multiple patients while charging each as a full vial, and claimed drugs prescribed but never administered. The scheme exploited Medicare and Medicaid reimbursement rates calibrated to actual acquisition costs, converting free or discounted drugs into full-price windfalls.

• •$1.45M False Claims Act settlement for systematic chemotherapy billing fraud
• •Three schemes: billing for unpurchased drugs, vial-splitting, and unadministered drugs
• •Exploited government reimbursement rates designed for actual acquisition costs

Generated with AI, which can make mistakes.